CATHERINE WILSON: Open Payments
NPI 1831667567 · FISHERSVILLE, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,021 in 52 payments from 13 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $1,021
Food & beverage: $1,021
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 12 | $204 |
| ABBVIE INC. | 10 | $160 |
| Madrigal Pharmaceuticals | 3 | $135 |
| Regeneron Healthcare Solutions, Inc. | 4 | $97 |
| Ardelyx, Inc. | 5 | $82 |
| Celltrion USA Inc. | 3 | $65 |
| Novo Nordisk Inc | 3 | $47 |
| Ipsen Biopharmaceuticals, Inc | 2 | $46 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $45 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $43 |
Products named: TREMFYA, REZDIFFRA, DUPIXENT, IBSRELA, CREON, VEGZELMA, Wegovy, IQIRVO.
Industry payments across VA — which companies pay providers there.
